Skip to main content
. 2020 Mar 2;318(5):F1100–F1112. doi: 10.1152/ajprenal.00607.2019

Table 2.

Baseline values in WT and Sglt2−/− mice

Genotype
Blood glucose, mg/dL
Urinary glucose, µmol/mg creatinine
FE-glucose, %
Body weight, g
Hematocrit, %
Plasma creatinine, mg/dL
Urine osmolality, mosm/kg
Plasma osmolality, mosm/kg
WT 151 ± 5 8.0 ± 0.6 0.10 ± 0.01 27.3 ± 0.7 43.1 ± 0.4 0.105 ± 0.002 1,736 ± 91 284 ± 3.3
Sglt2−/− 122 ± 5* 1,581 ± 124* 26.2 ± 2.3* 25.1 ± 0.4* 44.7 ± 0.4* 0.115 ± 0.004 (P = 0.058) 1,455 ± 42* 293 ± 3.5 (P = 0.079)

Results are means ± SE; n = 14–18 mice/group. Baseline data were not significantly different between sham-operated and ischemia-reperfused groups for a given genotype and thus were pooled. WT, wild type; Sglt2−/−, Na+-glucose transporter 2 knockout; FE-glucose, fractional renal excretion of glucose.

*

P < 0.05 vs. WT mice using an unpaired t test.